2m 2m 2m 2m 2m 2m 2m
ALLARITY (ALLR)
NASDAQ
$1.59-$0.10 (-6.21%)
Price as of Jun 03, 2026 6:26 PM EDT- $26.1MMarket Cap
- 92.26%1-Year Change
- BiotechnologyIndustry
ALLARITY (ALLR)
$1.59-$0.10 (-6.21%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 320,000 N/A | N/A N/A | N/A N/A | -1.3M 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 320,000 N/A | 0 +100.00% | -2.3M +68.15% | -1.3M 0.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -6.6M +8.28% | -6.1M -14.18% | -7.1M +2.50% | -6.9M -51.18% | |
Depreciation and Amortization Expense | N/A N/A | 9,000 -75.68% | 37,000 -38.33% | 60,000 -43.40% | |
Total Operating Expenses | 12.9M -52.55% | 27.2M +59.03% | 17.1M -50.30% | 34.5M +29.77% | |
Operating Profit | -12.6M -53.73% | -27.2M +59.03% | -17.1M -50.30% | -34.5M +29.77% | |
Interest Income | 801,000 +50.28% | 533,000 +2,322.73% | 22,000 -26.67% | 30,000 +106.06% | |
Interest Expense | -200,000 0.00% | -200,000 -59.84% | -498,000 -63.03% | -1.3M 0.00% | |
Interest Income and Expense and Net | 601,000 +80.48% | 333,000 +169.96% | -476,000 -63.86% | -1.3M -28.50% | |
Total Nonoperating Income and Expense | 1.4M -41.41% | 2.3M -55.85% | 5.3M -68.54% | 16.9M +41,080.49% | |
Income before Taxes | -11.2M -54.89% | -24.9M +110.66% | -11.8M -32.77% | -17.6M -33.70% | |
Income Taxes | 0 +100.00% | -381,000 -559.04% | 83,000 +105.46% | -1.5M -1,243.61% | |
Extraordinary Items | N/A N/A | N/A N/A | 3.6M -79.72% | 17.6M N/A | |
Net Income | -11.2M -54.19% | -24.5M +105.99% | -11.9M -25.89% | -16.1M -39.74% | |
Net Income from Continuing Operations Applicable to Common | -11.2M -55.35% | -25.2M +23.21% | -20.4M +27.14% | -16.1M -39.74% | |
Basic EPS and Net Income | -0.78 -95.02% | -15.65 +52.53% | -10.26 +364.25% | -2.21 -47.26% | |
Diluted EPS and Net Income | -0.78 -95.02% | -15.65 +52.53% | -10.26 +364.25% | -2.21 -47.26% | |
Basic Weighted Average Shares | 14.4M +794.78% | 1.6M -19.28% | 2.0M -79.10% | 9.5M +49.82% | |
Diluted Weighted Average Shares | 14.4M +794.78% | 1.6M -19.28% | 2.0M -79.10% | 9.5M +49.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 14.7M -24.81% | 19.5M +11,666.87% | 166,000 -91.82% | 2.0M -89.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 14.7M -24.81% | 19.5M +11,666.87% | 166,000 -91.82% | 2.0M -89.62% | |
Total Current Assets | 17.9M -19.75% | 22.3M +1,033.49% | 2.0M -60.33% | 5.0M -76.40% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 330,000 +6.80% | 309,000 +1,445.00% | 20,000 -4.76% | 21,000 +162.50% | |
Total Long-Term Assets | 330,000 +6.80% | 309,000 +1,445.00% | 20,000 -4.76% | 21,000 +162.50% | |
Total Assets | 18.3M -19.39% | 22.6M +90.95% | 11.9M -18.44% | 14.5M -70.70% | |
Income Taxes Payable | 81,000 +9.46% | 74,000 -85.35% | 505,000 +29.49% | 390,000 -80.70% | |
Total Short-Term Debt | 1.4M +3.70% | 1.4M +3.85% | 1.3M -50.83% | 2.6M +99.25% | |
Total Current Liabilities | 8.4M -22.23% | 10.8M -23.49% | 14.2M +26.24% | 11.2M -45.84% | |
Total Long-Term Debt | 1.4M -65.32% | 4.0M +39.74% | 2.9M -52.76% | 6.1M +217.54% | |
Total Long-Term Liabilities | 0 N/A | 0 -100.00% | 892,000 +27.79% | 698,000 -93.72% | |
Total Liabilities | 8.4M -22.23% | 10.8M -25.83% | 14.6M +15.48% | 12.7M -58.98% | |
Retained Earnings | -130.2M +9.44% | -119.0M +25.96% | -94.5M +14.42% | -82.5M +24.15% | |
Total Stockholders Equity | 9.8M -16.79% | 11.8M +529.33% | -2.8M +2,334.51% | -113,000 -100.62% | |
Total Shares Outstanding | 16.1M +120.20% | 7.3M +24.05% | 5.9M -62.97% | 15.9M +96.37% | |
Cash Flow | |||||
Cash from Operating Activities | -14.8M -14.59% | -17.4M +36.15% | -12.7M -24.21% | -16.8M +11.74% | |
Capital Expenditures | 8,000 -97.32% | 298,000 N/A | N/A N/A | 18,000 N/A | |
Cash from Investing Activities | -8,000 -97.32% | -298,000 N/A | N/A N/A | 791,000 -20.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.6M -71.06% | 36.8M +234.62% | 11.0M +938.67% | -1.3M -103.88% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -3,939.06% N/A | N/A N/A | N/A N/A | 2,558.50% N/A | |
Return on Assets | -54.91% -61.35% | -142.07% +57.61% | -90.14% +80.12% | -50.04% N/A | |
Return on Equity | -103.80% -80.82% | -541.17% -165.12% | 831.08% +566.80% | -178.04% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | 0.00% N/A | |
Current Ratio | 2.13 +3.18% | 2.06 +1,381.81% | 0.14 -68.58% | 0.44 N/A | |
Cash Ratio | 1.74 -3.32% | 1.80 +15,302.56% | 0.01 -93.53% | 0.18 N/A | |
Debt-to-Equity Ratio | 0.28 -37.54% | 0.46 +129.95% | -1.52 -98.04% | -77.52 N/A | |
Debt-to-Assets Ratio | 0.15 -35.49% | 0.24 -32.65% | 0.35 -41.37% | 0.60 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow